Access cutting-edge adenovirus infection treatment through this clinical trial at a research site in Indianapolis. Study-provided care at no cost to qualified participants.
Access adenovirus infection specialists in Indianapolis at no cost
This study follows strict safety protocols and ethical guidelines
All study-related adenovirus infection treatment provided free
Related donor Adenovirus (ADV) specific cytotoxic T cells (CTLs) manufactured with the Miltenyi CliniMACS Prodigy Cytokine Capture System will be administered intravenously in in children, adolescents and young adults with refractory ADV infection post Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT), with primary immunodeficiencies (PID) or post solid organ transplant. Funding Source: FDA OOPD
Sponsor: New York Medical College
Check if you qualify for this adenovirus infection clinical trial in Indianapolis, IN
If you're searching for adenovirus infection treatment options in Indianapolis, IN, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Indianapolis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced adenovirus infection specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.